Institut Paoli Calmettes Colorectal Cancer Database
Recruiting
- Conditions
- Colorectal Neoplasms
- Registration Number
- NCT02869503
- Lead Sponsor
- Institut Paoli-Calmettes
- Brief Summary
Database of Institut Paoli-Calmettes patients diagnosed with colorectal cancer
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 22000
Inclusion Criteria
- Patients with a colorectal cancer diagnosis
Exclusion Criteria
- Non applicable
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival of patients with colorectal cancer 10 years Overall survival of all patients who come in the center
- Secondary Outcome Measures
Name Time Method Collection of patients characteristics 10 years Collection of characteristics of patients treated at Institut Paoli Calmettes in order to set up prospective or retrospective studies
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular subtypes of colorectal cancer are characterized in the NCT02869503 observational database?
How do biomarkers like MSI-H or PD-L1 correlate with treatment outcomes in NCT02869503 colorectal cancer patients?
What adverse events are associated with anti-EGFR therapies in RAS wild-type CRC cases from the Paoli-Calmettes database?
How does the NCT02869503 dataset compare to other registries in identifying prognostic markers for metastatic colorectal cancer?
What insights into combination therapies (e.g., anti-VEGF plus immunotherapy) emerge from the Paoli-Calmettes CRC database?
Trial Locations
- Locations (1)
Institut Paoli Calmettes
🇫🇷Marseille, Bouches du Rhone, France
Institut Paoli Calmettes🇫🇷Marseille, Bouches du Rhone, FranceDominique Genre, MDContact0033491223778drci.up@ipc.unicancer.fr